SCRC CORE SHAREHOLDERS : > POWERFULL REVENUE NEWS OUT THIS

New Post Public Reply Private Reply Replies (0) Message Board
tryz
SCRC CORE SHAREHOLDERS : > POWERFULL REVENUE NEWS OUT THIS MORNING!!!.....OUR JOURNEY BEGINS: > ....May 21, 2014 - 8:00 AM EDT

ScripsAmerica Reports 126% Quarterly Revenue Growth YoY During Q1 2014
Company Records Over $5 Million in Revenue During Q1 2014 and CEO Comments on Revenue Recognition
TYSONS CORNER, VA--(Marketwired - May 21, 2014) - ScripsAmerica Inc. (OTCBB: SCRC) today announced the filing of its 10Q for the quarter that ended March 31, 2014.

The Company reported $5,097,000 in revenue during Q1 2014 compared to $2,256,000 in Q1 2013, marking a 126% increase in quarterly revenue year over year. ScripsAmerica's 2014 first quarter revenue from operations as reported in the 'Statement of Operations' in the Company's latest 10Q filing was $823,859, marking an increase of 187% over the same period in 2013 when it was reported at $287,374.

Gross profit during Q1 2014 was $598,000 compared to a loss of $11,000 for Q1 2013. The Company generated $3,687,222 in revenue from its joint government contract during the first quarter of 2014 compared to $1,955,345 during Q1 2013. This increase of $1,731,877 in quarterly revenue equals an 88% YoY growth rate for this contract.

This revenue is reported on page 30 of ScripsAmerica's 10Q in the 'Products Sold' column in the 'Revenue Net' section in addition to $793,000 in Q1 revenue from its pharmaceutical partner. Due to financial reporting requirements, ScripsAmerica can report only the net profits from its joint government contract and pharmaceutical partner, Wholesale Rx and not its top line revenue.

Commenting on ScripsAmerica's first quarter results, CEO Bob Schneiderman stated, "ScripsAmerica is pleased to report very positive financial results during the first quarter of 2014, marking the strong start we expected for what we believe will be a breakout year for the Company and its shareholders.

"It is also very important to remind the investment community that the Company's necessary accounting method has a significant impact on the reportable revenues from our government joint venture and Wholesale Rx investment, both of which will continue to generate revenue and profits for ScripsAmerica.

"The Company experienced tremendous growth across the business from our pharmaceutical equity venture with WRx to receiving an initial order for RapiMed in Asia as well as taking on the management of a specialty pharmacy that generated revenues of $494,643 in March before nearly doubling to $958,234 in April.

"We expect to see continued revenue growth in the upcoming quarters from our managed specialty pharmacy, equity ventures with WRx and PIMD International and our joint government contract which should lead to a sizeable increase in shareholder value."

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.




ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 3

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 8

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 10

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 20

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 6

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 6

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 10

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 7

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 4

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading

Top 5 Most Recently Viewed Articles

Thermo Fisher Scientific Reports Steady Q3 Performance

Updated Category News Views 69

Thermo Fisher Scientific's Q3 Performance Overview Thermo Fisher Scientific Inc. (NYSE: TMO) recently shared its financial results for the third quarter, revealing revenue of approximately $10.59 billion. While this figure is nearly unchanged compared to the previous year, it slightly fell short of the anticipated consensus of $10.64 billion. Segment Performance Analysis...

Continue Reading
Consumer Insights and Retail Earnings: Navigating New Trends

Updated Category News Views 213

Examining Retail Earnings and Consumer Sentiment This week marks a significant moment for the retail industry as key players prepare to unveil their earnings reports. The anticipation builds as we await insights from top retailers this week. Recently, the U.S. Census Bureau shared insights on retail sales, revealing mixed results. While the figures aren’t staggering,...

Continue Reading
Surge Copper Corp. Delivers Long-Term Equity Incentives to Team

Updated Category News Views 157

Surge Copper Corp. Grants Equity-Based Incentives Surge Copper Corp. (TSXV: SURG) is excited to announce a significant development in its incentive program aimed at enhancing team engagement. As part of its Share Compensation Plan, the Company has awarded a substantial number of long-term equity-based incentive awards to its dedicated employees and executives. Details of...

Continue Reading
Stepan Company Welcomes New Leadership in Finance

Updated Category News Views 204

Stepan Company Welcomes New Vice President and CFO Stepan Company, a leader in the specialty and intermediate chemicals sector, proudly announces the appointment of Ruben Velasquez as their new Vice President and Chief Financial Officer. This significant move signifies Stepan's commitment to strengthening its financial leadership. Mr. Velasquez's role becomes effective...

Continue Reading
Kiana Mehring Breaks Ground in Oncology Leadership

Updated Category News Views 9

Award-Winning Leadership in Oncology In the world of oncology, it's not every day that you see a young leader make waves like Kiana Mehring from Florida Cancer Specialists & Research Institute (FCS). This lady just nabbed the 40 Under 40 in Cancer Award, shining a light on the complicated dance of payer strategies and patient care. Recognizing folks like Mehring, who’s...

Continue Reading